Trademark Search in Canada

GW PHARMACEUTICALS & DESIGN

View On IC.GC.CA

REGISTERED

on 20 Sept 2022

Last Applicant/ Owned by

Jazz Pharmaceuticals Operations UK Limited

Building 730 Kent Science ParkSittingbourne, KentEngland, ME9 8AG

Serial Number

1936408 filed on 17^th Dec 2018

Registration Number

TMA1142335 registered on 20^th Sept 2022

Registration expiry Date

20^th Sept 2032

Correspondent Address

OSLER, HOSKIN & HARCOURT LLP

Suite 320, World Exchange Plaza100 Queen StreetOttawa,

ONTARIO

K1P1J9

GW PHARMACEUTICALS & DESIGN

Trademark usage description

pharmaceutical and veterinary preparations and substances for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex Read More

Vienna Information

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 11

Letters underlined, overlined, framed or barred by one or more strokesLettres soulignées, surlignées, encadrées ou barrées d'un ou de plusieurs traits

27 . 5 . 19

Letters overlappingLettres se chevauchant

26 . 11 . 2

Two lines or bandsDeux lignes ou bandes

26 . 11 . 8

Horizontal lines or bandsLignes ou bandes horizontales

26 . 11 . 10

Straight lines or bandsLignes ou bandes droites

Classification Information

Class [005]
Pharmaceutical and veterinary preparations and substances for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex, autism spectrum disorders, epilepsy, paediatric epilepsy, oncology, psychiatric disorders, namely anxiety, mood disorders, cognitive, bipolar disorders, schizophrenia, depression and post-traumatic stress disorder, type II diabetes, inflammation, cancer pain, MS spasticity and neonatal hypoxic-ischemic encephalopathy; pharmaceutical preparations and substances for the treatment of epilepsy; pharmaceutical preparations and substances for the treatment of pediatric epilepsy; pharmaceutical preparations and substances for the treatment of convulsions, seizures, Dravet syndrome, Lennox-Gastaut syndrome, intractable childhood epilepsy with generalized tonic-clonic seizures, generalized epilepsy with febrile seizures plus, Doose syndrome and chromosome disorders; herbs for medicinal purposes, namely for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex, autism spectrum disorders, epilepsy, paediatric epilepsy, oncology, psychiatric disorders, namely anxiety, mood disorders, cognitive, bipolar disorders, schizophrenia, depression and post-traumatic stress disorder, type ll diabetes, inflammation, cancer pain, MS spasticity and neonatal hypoxic-ischemic encephalopathy; medicinal herbs for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex, autism spectrum disorders, epilepsy, paediatric epilepsy, oncology, psychiatric disorders, namely anxiety, mood disorders, cognitive, bipolar disorders, schizophrenia, depression and post-traumatic stress disorder, type II diabetes, inflammation, cancer pain, MS spasticity and neonatal hypoxic-ischemic encephalopathy; medicinal oils for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex, autism spectrum disorders, epilepsy, paediatric epilepsy, oncology, psychiatric disorders, namely anxiety, mood disorders, cognitive, bipolar disorders, schizophrenia, depression and post-traumatic stress disorder, type ll diabetes, inflammation, cancer pain, MS spasticity and neonatal hypoxic-ischemic encephalopathy; medicinal infusions for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex, autism spectrum disorders, epilepsy, paediatric epilepsy, oncology, psychiatric disorders, namely anxiety, mood disorders, cognitive, bipolar disorders, schizophrenia, depression and posttraumatic stress disorder, type ll diabetes, inflammation, cancer pain, MS spasticity and neonatal hypoxicischemic encephalopathy; medicinal infusions for the treatment of epilepsy, convulsions and seizures; pure extracts of medicinal plants and herbs for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex, autism spectrum disorders, epilepsy, paediatric epilepsy, oncology, psychiatric disorders, namely anxiety, mood disorders, cognitive, bipolar disorders, schizophrenia, depression and posttraumatic stress disorder, type II diabetes, inflammation, cancer pain, MS spasticity and neonatal hypoxicischemic encephalopathy; foodstuffs for medicinal purposes, namely, plant oil for the treatment of neurological diseases and conditions such as epilepsy and paediatric epilepsy, oncology, psychiatric disorders such as mood disorders and schizophrenia, type II diabetes, inflammation, cancer pain, multiple sclerosis spasticity and neonatal hypoxic-ischemic encephalopathy; dietary supplements for humans and animals, namely for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex, autism spectrum disorders, epilepsy, paediatric epilepsy, oncology, psychiatric disorders, namely anxiety, mood disorders, cognitive, bipolar disorders, schizophrenia, depression and post-traumatic stress disorder, type II diabetes, inflammation, cancer pain, MS spasticity and neonatal hypoxic-ischemic encephalopathy; dietetic food and substances adapted for medical and veterinary use containing cannabinoids; food for babies; herb teas for medicinal purposes, namely for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex, autism spectrum disorders, epilepsy, paediatric epilepsy, oncology, psychiatric disorders, namely anxiety, mood disorders, cognitive, bipolar disorders, schizophrenia, depression and posttraumatic stress disorder, type II diabetes, inflammation, cancer pain, MS spasticity and neonatal hypoxicischemic encephalopathy; medications for the treatment of multiple sclerosis, pain associated with cancer, neuropathies and rheumatoid arthritis; medicines for the treatment of symptoms namely, pain, muscle spasticity and spasms, bladder problems and sleep disorders; medications for the treatment of conditions to which neuropathic pain is associated, namely, multiple sclerosis, cancer, spinal cord injury, physical trauma and peripheral neuropathy resulting from diabetes; medicines for the treatment of anorexia-cachexia, the result of cancer and AIDS, and nausea, and secondary vomiting due to chemotherapy treatments.

Classification kind code

Class [031]
Agricultural and horticultural products, namely, cannabis seeds for agricultural and horticultural purposes; agricultural seeds; seedlings for plant breeding; live flowers; live plants; plant residues, namely, cannabinoid oil for animal consumption, not medicinal; fresh herbs; foodstuffs and beverage for animals containing cannabinoids, not medicinal.

Classification kind code

Mark Details

Serial Number

1936408

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 190 on 24^th Aug 2022	Registration Pending
Submitted for opposition 191 on 24^th Aug 2022	Registration Fee Notice Sent
Submitted for opposition 42 on 1^st Jun 2022	Advertised
Submitted for opposition 27 on 25^th Mar 2022	Approval Notice Sent
Submitted for opposition 26 on 25^th Mar 2022	Approved
Submitted for opposition 22 on 18^th Oct 2021	Search Recorded
Submitted for opposition 20 on 18^th Oct 2021	Examiner's First Report
Submitted for opposition 31 on 21^st Dec 2018	Formalized
Submitted for opposition 1 on 18^th Dec 2018	Created
Submitted for opposition 30 on 17^th Dec 2018	Filed